Impact of Fiasp on Glycaemic Control in a Real World Population With Type 1 Diabetes Mellitus Using Flash Glucose Monitoring
Phase of Trial: Phase IV
Latest Information Update: 12 Feb 2019
At a glance
- Drugs Insulin aspart (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Acronyms GoBolus
- Sponsors Novo Nordisk
- 01 Feb 2019 Planned End Date changed from 28 Feb 2019 to 31 Aug 2019.
- 01 Feb 2019 Planned primary completion date changed from 31 Dec 2018 to 31 Aug 2019.
- 31 Aug 2018 Biomarkers information updated